https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Editorhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgEditor2022-07-22 17:03:082022-08-17 15:25:02In vitro evaluation of AUT00206, a novel and selective Kv3 channel modulator for the treatment of schizophrenia
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Editorhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgEditor2022-07-22 16:56:312022-08-17 15:09:24Early clinical evaluation of AUT00206, a novel and selective Kv3 channel modulator for the treatment of schizophrenia
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Editorhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgEditor2022-07-22 15:24:112022-08-17 15:25:12AUT00206 restores cognitive function in an animal model in 2 tasks in the presence of antipsychotic drugs
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Editorhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgEditor2014-04-09 23:59:432022-08-17 15:11:02A novel Kv3 positive modulator augments gamma frequency oscillations in the mammalian neocortex in vitro
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Editorhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgEditor2014-04-09 23:58:042022-08-17 15:11:08Efficacy and relevance of the modulation of Kv3 channels to alleviate cognitive dysfunction in an animal model of schizophrenia symptomatology
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Editorhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgEditor2014-04-09 23:57:232022-08-17 15:11:14Two novel KV3 ion channel modulators alleviate cognitive dysfunction and social behaviour deficits of relevance to schizophrenia in an animal model
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Editorhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgEditor2013-11-13 23:59:342022-08-17 15:11:27Pharmacological activators and inhibitors of Kv3.1 potassium currents
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Editorhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgEditor2013-10-18 23:59:482022-08-17 15:11:39A novel Kv3 ion channel modulator restores cognitive function in an animal model of cognitive impairment in schizophrenia
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Editorhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgEditor2013-02-20 23:59:402022-08-17 15:11:54Pharmacological activators and inhibitors of Kv3.1 potassium currents
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Editorhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgEditor2012-10-17 23:59:332022-08-17 15:12:06Potential anti-manic efficacy of a Kv3 channel modulator in a model of amphetamine-induced hyperactivity and in CLOCKΔ19 mutant mice